pluronic, lecithin, organogel, PLO, topical administration, dementia
Geriatrics | Pharmaceutical Preparations | Psychiatry
OBJECTIVE: Treatment of mood and behavioral symptoms in geriatric patients with advanced dementia may be impeded by poor compliance with oral medications. Pluronic lecithin organogel (PLO) is a compounding substrate that can be used for the topical administration of psychotropic medications.
METHODS: Charts of patients treated with psychotropic medications compounded with PLO cream were reviewed for treatment outcomes. All patients were treated by a nursing home outreach service.
RESULTS: Records from twenty-four patients, mean age 86.8 + 5.9, were reviewed. Common psychiatric symptoms included agitation, aggressive behavior, and depression. Medications most commonly administered as a PLO cream included quetiapine and venlafaxine. All patients had mild to marked improvement in psychiatric symptoms.
CONCLUSIONS: Pluronic lecithin organogel (PLO) may be an effective option for the topical administration of psychiatric medications in geriatric patients with dementia who are not compliant with oral medications.
Thomas,, Cornelius W. MD and Holroyd,, Suzanne MD. Chair, Department of Psychiatry
"Topical administration of psychotropic medications in pluronic lecithin organogel to treat patients with dementia: A retrospective observational study,"
Marshall Journal of Medicine:
1, Article 4.
Available at: https://mds.marshall.edu/mjm/vol1/iss1/4